Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABSINASDAQ:IBEXNYSE:NOTENYSE:TRAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$2.78-2.1%$2.88$2.01▼$6.33$354.61M2.062.81 million shs2.22 million shsIBEXIBEX$27.89-7.1%$26.58$15.15▼$32.08$372.95M0.78137,389 shs381,880 shsNOTEFiscalNote$0.51-3.6%$0.63$0.48▼$2.07$80.85M0.611.71 million shs3.77 million shsTRAKRepositrak$20.51-1.6%$0.00$14.23▼$25.01$374.84M0.5447,022 shs37,764 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci0.00%-8.25%-6.08%-11.46%-43.95%IBEXIBEX0.00%-6.75%-1.48%+12.19%+71.53%NOTEFiscalNote0.00%-16.37%-25.14%-43.85%-59.28%TRAKRepositrak0.00%-6.77%-5.05%+2,050,999,900.00%+2,050,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSIAbsci2.1142 of 5 stars3.51.00.00.02.71.70.6IBEXIBEX1.2131 of 5 stars1.03.00.00.02.52.51.3NOTEFiscalNote2.3767 of 5 stars3.51.00.00.01.93.30.6TRAKRepositrak0.3082 of 5 stars0.00.00.80.02.42.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSIAbsci 3.00Buy$8.40202.16% UpsideIBEXIBEX 2.00Hold$27.00-3.19% DownsideNOTEFiscalNote 3.00Buy$2.63415.33% UpsideTRAKRepositrak 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NOTE, TRAK, IBEX, and ABSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.005/13/2025NOTEFiscalNoteD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.75 ➝ $3.755/12/2025IBEXIBEXBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/12/2025IBEXIBEXRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Neutral$30.00 ➝ $30.005/1/2025NOTEFiscalNoteLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$2.504/16/2025ABSIAbsciKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$5.00 ➝ $9.004/9/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/20/2025ABSIAbsciGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.003/19/2025ABSIAbsciHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.00 ➝ $7.003/19/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.003/17/2025NOTEFiscalNoteD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.75 ➝ $3.75(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSIAbsci$4.82M73.65N/AN/A$1.90 per share1.46IBEXIBEX$535.67M0.70$3.45 per share8.08$8.26 per share3.38NOTEFiscalNote$115.67M0.70N/AN/A$0.33 per share1.55TRAKRepositrak$22.03M17.02N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSIAbsci-$110.57M-$0.92N/AN/AN/A-2,321.56%-46.56%-39.74%8/13/2025 (Estimated)IBEXIBEX$33.65M$2.2913.09∞N/A7.08%25.29%13.16%N/ANOTEFiscalNote-$115.46M-$0.33N/AN/AN/A-22.27%-88.72%-22.29%8/6/2025 (Estimated)TRAKRepositrakN/A$0.3460.32∞N/AN/AN/AN/AN/ALatest NOTE, TRAK, IBEX, and ABSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ABSIAbsci-$0.23-$0.21+$0.02-$0.21$1.07 million$1.18 million5/12/2025Q1 2025NOTEFiscalNote-$0.10-$0.12-$0.02-$0.03$26.43 million$27.51 million3/18/2025Q4 2024ABSIAbsci-$0.22-$0.25-$0.03-$0.25$1.77 million$0.67 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSIAbsciN/AN/AN/AN/AN/AIBEXIBEXN/AN/AN/AN/AN/ANOTEFiscalNoteN/AN/AN/AN/AN/ATRAKRepositrak$0.080.39%N/A23.53%2 YearsLatest NOTE, TRAK, IBEX, and ABSI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/5/2025TRAKRepositrakquarterly$0.020.37%9/30/20259/30/202511/14/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSIAbsci0.015.635.63IBEXIBEX0.011.441.44NOTEFiscalNote1.440.810.81TRAKRepositrakN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSIAbsci52.05%IBEXIBEX81.24%NOTEFiscalNote54.31%TRAKRepositrak27.35%Insider OwnershipCompanyInsider OwnershipABSIAbsci10.49%IBEXIBEX6.72%NOTEFiscalNote40.16%TRAKRepositrak44.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSIAbsci210127.56 million103.59 millionOptionableIBEXIBEX30,00013.37 million12.31 millionNot OptionableNOTEFiscalNote790158.22 million82.26 millionOptionableTRAKRepositrak7018.28 millionN/AN/ANOTE, TRAK, IBEX, and ABSI HeadlinesRecent News About These CompaniesReposiTrak: Strong Fundamentals, But A Premium ValuationJune 13 at 1:53 PM | seekingalpha.comInsider Unloading: Randall K Fields Sells $160K Worth Of ReposiTrak SharesJune 13 at 3:51 AM | benzinga.comInsider Selling: Repositrak, Inc. (NYSE:TRAK) CEO Sells 1,500 Shares of StockJune 12 at 9:37 AM | insidertrades.comRepositrak (NYSE:TRAK) Shares Down 4.3% on Insider SellingJune 12 at 1:47 AM | americanbankingnews.comRepositrak (NYSE:TRAK) Stock Price Down 4.3% Following Insider SellingJune 12 at 12:28 AM | marketbeat.comRepositrak, Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 1,500 SharesJune 11, 2025 | marketbeat.comRepositrak, Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 2,500 SharesJune 11, 2025 | marketbeat.comInsider Selling: Repositrak, Inc. (NYSE:TRAK) CEO Sells 3,500 Shares of StockJune 11, 2025 | marketbeat.comRitter Sport USA, Inc. Partners with ReposiTrak to Proactively Deliver Outbound Food Traceability Data to U.S. RetailersJune 10, 2025 | businesswire.comRepositrak CEO Randall Fields sells $159,659 in company stockJune 6, 2025 | investing.comReposiTrak, Inc. Declares its Third 10% Increase in its Quarterly Cash DividendJune 5, 2025 | finance.yahoo.comRepositrak, Inc. (NYSE:TRAK) Announces Quarterly Dividend of $0.02June 5, 2025 | marketbeat.comRepositrak, Inc. (NYSE:TRAK) CEO Sells $53,100.00 in StockJune 5, 2025 | insidertrades.comRandall K Fields Takes Money Off The Table, Sells $159K In ReposiTrak StockJune 4, 2025 | benzinga.comRepositrak, Inc. (NYSE:TRAK) CEO Sells $53,100.00 in StockJune 4, 2025 | marketbeat.comRepositrak, Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 5,000 SharesJune 4, 2025 | marketbeat.comReposiTrak Adds 50 New Food and Beverage Suppliers to the Queue for the Rapidly Expanding Food Traceability NetworkJune 3, 2025 | businesswire.comRandall K. Fields Sells 2,500 Shares of Repositrak, Inc. (NYSE:TRAK) StockMay 30, 2025 | marketbeat.comRepositrak, Inc. (NYSE:TRAK) CEO Sells $111,550.00 in StockMay 30, 2025 | marketbeat.comRepositrak CEO Randall Fields sells $167,220 in stockMay 29, 2025 | investing.comRepositrak, Inc. (NYSE:TRAK) CEO Sells $55,650.00 in StockMay 29, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Top-Rated Energy Companies Staging Strong RecoveriesBy Nathan Reiff | June 2, 2025View 3 Top-Rated Energy Companies Staging Strong RecoveriesIntel's Price Spikes: Noise, or the First Notes of a Turnaround?By Jeffrey Neal Johnson | June 13, 2025View Intel's Price Spikes: Noise, or the First Notes of a Turnaround?NOTE, TRAK, IBEX, and ABSI Company DescriptionsAbsci NASDAQ:ABSI$2.78 -0.06 (-2.11%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.80 +0.02 (+0.72%) As of 06/13/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.IBEX NASDAQ:IBEX$27.89 -2.14 (-7.13%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$27.90 +0.02 (+0.05%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience. It operates customer engagement and customer acquisition delivery centers. The company serves banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utility industries. The company was formerly known as IBEX Holdings Limited and changed its name to IBEX Limited in September 2019. IBEX Limited was incorporated in 2017 and is headquartered in Washington, District of Columbia. The company is a subsidiary of The Resource Group International Limited.FiscalNote NYSE:NOTE$0.51 -0.02 (-3.64%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$0.52 +0.01 (+1.57%) As of 06/13/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FiscalNote Holdings, Inc. operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. The company also delivers that intelligence through its suite of public policy and issues management products, as well as powerful tools to manage workflows, advocacy campaigns, and constituent relationships. It serves a customer base that includes businesses comprising the Fortune 100 companies, government agencies, law firms, professional services organizations, trade groups, and non-profits. FiscalNote Holdings, Inc. is headquartered in Washington, District Of Columbia.Repositrak NYSE:TRAK$20.51 -0.34 (-1.63%) As of 06/13/2025 03:59 PM EasternPark City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
